Skip to content

Drug interactions

Sofosbuvir-velpatasvir-voxilaprevir + Tafamidis

Severity: Minor

Sofosbuvir-velpatasvir-voxilaprevir and Tafamidis: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Tafamidis inhibits BCRP in vitro and could increase velpatasvir exposure. The clinical effect is probably small, and velpatasvir has a wide margin of safety.

What this interaction means in plain words

Sofosbuvir-velpatasvir-voxilaprevir and Tafamidis have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Sofosbuvir-velpatasvir-voxilaprevir belongs to Anti Virals; Tafamidis belongs to Cardiovascular.

Evidence level: Low

Why it happens

Tafamidis inhibits BCRP-mediated efflux of velpatasvir, as shown in vitro.

What to do

No routine dose change is needed. Monitor for antiviral adverse effects such as headache and fatigue.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Sofosbuvir-velpatasvir-voxilaprevir and Tafamidis, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Sofosbuvir-velpatasvir-voxilaprevir with Tafamidis?

MediHelp rates the interaction as minor. Sofosbuvir-velpatasvir-voxilaprevir and Tafamidis have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Tafamidis inhibits BCRP in vitro and could increase velpatasvir exposure. The clinical effect is probably small, and velpatasvir has a wide margin of safety.

How serious is the interaction between Sofosbuvir-velpatasvir-voxilaprevir and Tafamidis?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine dose change is needed. Monitor for antiviral adverse effects such as headache and fatigue.

What other medicines interact with Sofosbuvir-velpatasvir-voxilaprevir?

MediHelp also lists interactions of Sofosbuvir-velpatasvir-voxilaprevir with, for example, Fosphenytoin, Phenobarbital, Phenytoin. The full list is on the Sofosbuvir-velpatasvir-voxilaprevir page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in